Form 4: Craig H. Barratt Executes Stock Option and Sells Shares of Intuitive Surgical Inc.

Director Craig H. Barratt exercised stock options and sold shares of Intuitive Surgical Inc. on June 3, 2024, according to a Form 4 filing with the SEC.

Summary

• On June 3, 2024, Craig H. Barratt, a director of Intuitive Surgical Inc. (ISRG), executed non-qualified stock options to acquire 1,400 and 1,096 shares of common stock at an exercise price of $56.9744 per share.
• Concurrently, Barratt sold 1,400 and 1,096 shares of Intuitive Surgical Inc. common stock at a price of $402.89 per share.
• These transactions were conducted under a pre-arranged trading plan complying with SEC Rule 10b5-1, set to expire on March 4, 2025.
• Following these transactions, Barratt directly owns 5,296 and 4,200 derivative securities and indirectly owns 26,155 shares through a trust.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports stock transactions by a company director under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The transactions were executed under a pre-arranged trading plan, suggesting a continuation of similar transactions may occur until the plan's expiration on March 4, 2025.

Industry Context

Executive stock transactions are common and closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan indicates a pre-arranged strategy to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with shareholders.
• Rule 10b5-1 trading plans are a standard practice among corporate executives to manage stock sales in a compliant manner.
• The sale price of $402.89 per share reflects the current market valuation of Intuitive Surgical, which is a key player in the robotic surgery market.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's stock sales.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates